Ophthalmic manifestations in the COVID-19 clinical spectrum.

Autor: Kumar KK; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Sampritha UC; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Prakash AA; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Adappa K; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Chandraprabha S; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Neeraja TG; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Guru Prasad NS; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Basumatary J; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Gangasagara SB; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Sujatha Rathod BL; Department of Ophthalmology, Regional Institute of Ophthalmology, Minto Ophthalmic Hospital, Bengaluru, Karnataka, India., Jayanthi CR; Department of Pharmacology, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
Jazyk: angličtina
Zdroj: Indian journal of ophthalmology [Indian J Ophthalmol] 2021 Mar; Vol. 69 (3), pp. 691-694.
DOI: 10.4103/ijo.IJO_3037_20
Abstrakt: Purpose: The aim of this study was to determine the frequency and various types of ophthalmic manifestation of patients with COVID-19.
Methods: This is a prospective observational study conducted on patients with SARS-Co-V-2 infection, at a dedicated tertiary COVID-19 hospital in South India from April 1 to July 31, 2020. At the time of their admission to the COVID hospital, demographic data such as name, age, sex was recorded. A thorough history regarding the onset, duration, progression, nature of symptoms and its associated factors, medication history, treatment history were elicited and documented. Ocular examination was performed under torchlight by an ophthalmologist posted for COVID duty. Further investigations including imaging were sought for, depending on clinical indications. Serial follow-up examinations of all patients were carried out every 72 hours or when patients complained of any ocular symptoms whichever earlier, until discharge. All relevant data were compiled and statistically analyzed.
Results: A total of 2742 patients were examined. Of them, 1461 (53.28%) were males and 1281 (46.72%) were females. The mean age (±SD) was 39.46 ± 17.63 years. None of the patients in our study had any ocular symptoms or signs as the presenting complaint at the time of their admission. On subsequent follow-up, only 20 (0.72%) developed ocular manifestations, of which 19 (95%) had features suggestive of Bilateral viral conjunctivitis. However, 1 (5%) patient had orbital cellulitis secondary to pansinusitis.
Conclusion: Ophthalmic manifestations in the clinical spectrum of COVID-19 infection are uncommon and unlikely to be the presenting clinical impression. However, it has broadened our view to a wider spectrum of COVID-19 presentations enhancing our clinical acumen for staunch detection of COVID-19 suspects in our daily practice, augmenting early diagnosis and management and also break the chain of transmission for the greater good of humanity.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje